Surgical Masks Market: Post-COVID Prospects

1
Surgical Masks Market Post-COVID
Prospects Short-term demand for surgical masks
remains unprecedented however, growing awareness
regarding their effectiveness will lead to steady
sales in the long term. Our study estimates the
global surgical masks market to surge at a CAGR
of 10.2 during the forecast period 2022-2028.
This growth is fueled by the growing awareness of
healthcare-associated infections (HAI) and a rise
in healthcare expenditure. According to the World
Health Organization (WHO), hundreds of millions
of individuals are impacted by healthcare-associat
ed infections (HAIs) annually, resulting in death
and financial losses for healthcare systems.
Furthermore, factors such as an aging population,
the prevalence of chronic and long-term diseases,
and increased investments in medical technology
advanced infrastructure will increase healthcare
spending globally.
Why is Asia-Pacific a Promising Region in the
Surgical Mask Market? Asia-Pacific is
anticipated to be the fastest-growing region in
the surgical masks market. The increasing elderly
population and growing healthcare infrastructure
are likely to boost the demand
2
for healthcare services. Improving hygiene and
safety standards leads to increased use of
surgical masks, thereby positively impacting the
studied market. Fluid/splash resistant surgical
masks leads the product segment in 2021. The
growth is associated with the ability of the
Splash Resistant technology, which prevents the
wearer from droplet infections during any
surgical procedure or management of any patients
prone to the transmission of the diseases. On the
other hand, India holds a significant prominence
in the Asia-Pacific market. The healthcare
business in the country is anticipated to expand
greatly due to the growing population, increased
disposable incomes, improved access to insurance,
heightened health awareness, and rising spending
by public and private industry participants. In
addition, the growing incidence of obesity has
led to an increase in chronic ailments, such as
heart disease and diabetes, which necessitate
various healthcare treatments and services. This
is expected to contribute to the expansion of the
market for surgical masks. However, strict
government regulations, coupled with the emerging
use of substitutes such as N95 masks, are
anticipated to hinder the growth of the surgical
masks market. Due to the COVID-19 pandemic, there
was a dearth of personal protective equipment,
such as surgical masks. This forced the medical
staff members performing front-line activities to
adopt additional face protection measures,
including non-medical masks, simple cloth masks,
N95/N99/FFP2/FFP3 respirators, power
air-purifying respirators, and face
shields/visors, etc. Technological Integration
The Way Forward New technology by Ascend
Performance Materials is used to manufacture
high-efficacy surgical masks to protect against
SARS-CoV-2. This technology has shown positive
results for deactivating SARS-CoV-2 and other
pathogens such as staphylococcus, betacoronavirus
OC43, and H1N1. However, it is still awaiting
patent and FDA approval. The masks manufactured
using this technology combine antiviral
protection and superior physical properties
meeting the requirements to qualify as Level III
under ASTM F2100-19 standards. In July 2020,
Ascend Performance Materials announced the
submission of a 510(k) premarket notification to
the US FDA for clearance of its surgical mask
that uses Acteev technology to offer protection
against SARS-CoV-2. Thus, improvements in the
manufacturing of reusable non-woven materials,
such as antimicrobial fibers and increased
comfort, will propel the expansion of the
surgical masks market during the forecast period.
3
FAQs Q1) What are the segments covered in the
surgical masks market? Product, type, material,
distribution channel, and end-user are the
segments covered in the surgical masks market.
Q2) Who are the key players in the surgical masks
market? The key companies studied in the surgical
masks market are 3M, Mediblue Health Care Private
Ltd, Cardinal Health, Kimberly-Clark Corporation,
Alphaprotech, Ansell Ltd, Magnum Health and
Safety Pvt Ltd, and Dupont De Nemours Inc.